Primary malignant tumours of the anus

Area of Science:

• Oncology
• Gastroenterology
• Surgical Pathology

Background:

• Primary malignant anal tumors are rare but present unique diagnostic and therapeutic challenges.
• Understanding the epidemiology and histology of these tumors is crucial for effective management.
• The Health Sciences Centre in Winnipeg served as the study site for this retrospective analysis.

Purpose of the Study:

• To review the clinical presentation, histological types, and treatment outcomes of primary malignant anal tumors.
• To identify prognostic factors and evaluate the efficacy of different treatment modalities.
• To contribute to the understanding of this rare malignancy.

Main Methods:

• Retrospective review of 17 patients (6 men, 11 women) diagnosed with primary malignant anal tumors between 1968 and 1977.
• Analysis of patient demographics, presenting symptoms, histological findings, treatment regimens, and survival data.
• Histological classification included cloacogenic and squamous cell carcinomas as the predominant types.

Main Results:

• The mean patient age was 64 years, with presenting complaints including anal mass and rectal bleeding.
• Over 70% of tumors were histologically identified as cloacogenic or squamous carcinomas.
• Abdominoperineal resection, with or without radiotherapy, was the primary treatment; local excision was used in select cases. Eight patients died within 2 years, while nine survived an average of 6 years, with two experiencing recurrence.

Conclusions:

• Malignant anal tumors, predominantly cloacogenic and squamous carcinomas, require tailored treatment strategies.
• Surgical intervention, often combined with radiotherapy, remains a cornerstone of management.
• Long-term follow-up is essential to monitor for recurrence and manage treatment sequelae.